Journal of Food Bioactives, ISSN 2637-8752 print, 2637-8779 online |
Journal website www.isnff-jfb.com |
Review
Volume 7, September 2019, pages 18-26
Anticancer and antiproliferative properties of food-derived protein hydrolysates and peptides
Table
Source | Protein hydrolysates/Peptide | Production Method | Cellular and/or animal model | IC50 value | Mechanism | References |
---|---|---|---|---|---|---|
*Cell lines Key: MCF-6, MCF-7, MDA-MB-231, BT549–breast cancer; HeLa–cervical cancer; Caco-2, HCT-116, TC7, DLD-1–colon cancer; DU-109–esophageal cancer; NIH3T3–mouse fibroblast; HT1080–fibrosarcoma; U87-glioma; L1210- lymphocytic leukemia; HepG-2–liver cancer; A549, DU-1299–lung cancer; U937–histiocytic lymphoma; HT-29, P388D1-mouse monocyte macrophage cell line; RAW264.7 (mouse)–macrophage; MC3T3E1–osteoblastic calvaria-derived cells; DU-145–prostate; UMR106–rat osteosarcoma-derived cells; AGS–stomach adenocarcinoma; HRA–human ovarian cancer; C33–epidermoid cervical carcinoma; B1F610-melanoma cells; SKVO-3–ovarian cancer cell; HUVEC–Human umbilical vein endothelial cells. | ||||||
Tuna cooking juice | KPEGMDPPLSEPEDRRDGAAGPK, KLPPLLLAKLLMSGKLLAEPCTGR | Enzymatic hydrolysis with Protease XXIII and ultrafiltration | Human breast cancer MCF-7 cells and MCF-10A mammary epithelial cells | 1.39 mg/mL | Apoptosis induction and tumour suppression | Hung et al., 2014 |
Peptides from Spirulina platensis | HVLSRAPR | Enzymatic hydrolysis and fractionation | HT-29 cancer cells | 99.88 µg/mL | Tumour suppression | Wang and Zhang, 2017 |
Mung bean vicilin | Protein hydrolysates and vicilin seed extracts | Ammonium sulfate fractionation of vicilin followed by separate hydrolyses with alcalase and trypsin | MCF-7 and MDA-MB-231 breast cancer cells | 0.32, 0.73 and 0.45 mg/mL for MCF-7; 0.26, 0.48 and 0.54 mg/ml for MDA-MB-231 cells | Tumour suppression | Gupta et al., 2018 |
Chickpea | Protein hydrolysates | Alcalase hydrolysis | Tumour-bearing mice | Not mentioned | Tumour suppression | Xue et al., 2012 |
Maize | Peptides | Alcalase hydrolysis followed by ion exchange column chromatography fractionation | Hepatocarcinoma human HepG2 cells | 1.5–150 µg/mL for peptide fractions and 0.001–1.5 mM for derived peptides. | Apoptosis induction, cell growth inhibition | Ortiz-Martinez et al., 2017 |
Soybean (germinated) | Peptide fractions | Extraction, precipitation, enzymatic hydrolysis and membrane fractionation | HeLa cells | 1.83 mg/mL | Apoptosis induction and down regulation of PTTG1 and TOP2A tumorigenic genes | Robles-Ramírez et al., 2012 |
Soybean | Lunasin | Simulated GIT digestion with pepsin and pancreatin | L1210 leukemia cells | 14 µM | Activation of Caspase-3 and dose-dependent G2 cell cycle arrest | González de Mejia et al, 2010 |
Soybean | Lunasin | Lunasin obtained by aqueous extraction from soybean followed by ion exchange and size exclusion chromatography, and further purified by HPLC separation | HT-29 colon cancer cells | 61.7 µM | Activation of mitochondrial pathways and increased induction of pro-apoptotic nuclear clusterin expression | Dia and Mejia, 2010 |
Soybean | XMLPSYSPY | Thermoase and ethanol extraction | P388D1 | 0.16 mg/mL | Not investigated | Kim et al., 2000 |
Soybean | Isoflavone-derived soy | Sequential hydrolysis with endopeptidase, exopeptidase and amylase in that order | MCF-7 | Not stated | Apoptosis via p21, p53, and caspase-3 expression, and inhibition of VEGF and HSP90 | Park et al., 2009 |
Soybean | Kunitz trypsin inhibitor | HRA human ovarian cancer cells | 2–3 µM | Inhibition of the upregulation of urokinase-type plasminogen activator, uPA, and its specific receptor, uPAR | Kobayashi et al, 2004 | |
Soybean | VFDGEL, IETWNPNNKP and FEITPEKNPQ | Pepsin and pancreatin | L1210 | 7.9, 4.0 and 2.4 mM in that order | Human topoisomerase II inhibition | Wang et al., 2008 |
Rapeseed | Rapeseed peptide | Alcalase and flavourzyme | HeLa | Not stated | DNA structural damage and apoptosis induction | Xue et al, 2010 |
Amaranthus mantegazzianus (seed) | Mantegazzianus peptide isolate | Alcalase | UMR106, Caco-2, TC7, MC3T3E1 | 1.0, 1.5 and 2.5 and 2.5 mg/mL respectively | Inhibition of cell adhesion, necrosis and apoptosis | Barrio and Añón, 2010 |
Walnut | Cys-Thr-Leu-Glu-Trp | Alkaline extraction, precipitation by centrifugation and hydrolysis with papain | Human HeLa cervical cancer and MCF-7 breast cancer cells | 0.60 and 0.65 mg/mL respectively | Induction of apoptosis and autophagy | Ma et al., 2015 |
Tilapia | Tilapia hepcidin (TH) 1–5 | Chemically synthesized | HeLa, HepG2, HT1080 | Not stated | Downregulation of interleukin (IL)-6, IL-8, IL-12, IL-15, interferon-γ, Bcl-2 and caspase-7, as well as upregulation of IL-2 and IL-8 | Chang et al, 2011 |
Estuary cod (Epinephelus coioides) | Epinecidin-1 | Chemically synthesized | A549, HepG2, HT1080, U937, NIH3T3, RAW264.7 cancer cells | Not stated | Inhibition of cell growth and cell lysis | Lin et al., 2009 |
Cuttlefish ink (Sepia esculenta) | An oligopeptide, N Gln-Pro-Lys | Trypsin | DU-145 prostate cancer cells | Variable | Inhibition of cell viability and growth | Ding et al, 2011 |
Tuna dark muscle byproduct | LPHVLTPEAGAT PTAEGGVYMVT | Papain and protease XXIII | MCF-7 | 8.1 µM and 8.8 µM respectively | Inhibition of cell viability and proliferation | Hsu et al., 2011 |
Loach (Misgurnus anguillicaudatus) | Loach peptide fractions | Loach tissue homogenization followed by papain hydrolysis | HepG2, MCF-7 and Caco-2 cells | Not stated | Inhibition of cell proliferation | You et al., 2011 |
Setipinna taty | Heated products from peptic hydrolysates of marine fish (half-fin anchovy) | Peptic hydrolysates heated for 10 min at 95 °C | DU-145 prostate, 1299 lung, and 109 esophagus cancer cells | 13.67, 25.17 and 40.28 mg/mL respectively | Cell proliferation inhibition | Song et al., 2011 |
Skate (Raja porosa) cartilage protein hydrolysate | FIMGPY | Enzymatic hydrolysis with pepsin, trypsin and chymotrypsin | HeLa | 4.81 mg/mL | Apoptosis and tumour suppression | Pan et al, 2016 |
Blue whiting cod, Plaice, Atlantic Salmon | Fish protein hydrolysates | pH-shift extraction followed by Protamex and alcalase hydrolysis | MCF-7/6, MDA-MB-231 and breast cancer cells | Not stated | Inhibition of cell growth and proliferation | Picot et al., 2006 |
Rice bran | Alacalase hydrolysis followed by simulated GIT digestion | Gastrointestinal juice | Caco-2, HepG2, HCT-116, MCF-7, MDA-MB-231 | Not mentioned | Not mentioned | Kannan et al., 2010 |
Snow crab (by-products) | KCl2 cationic peptide | Enzymatic hydrolysis with Protamex, electrodialysis, ultrafiltration | A549, HCT15, BT549, PC3 | Not mentioned | Not mentioned | Doyen et al., 2011 |
Squid gelatin | Squid gelatin protein hydrolysates | Protamex, trypsin, Neutrase, Savinase, NS37005, Esperase, Alcalase | MCF-7, U87 | 130 and 100 µg/mL for MCF-7 and U87 respectively | Not stated | Alemán et al., 2011 |
Rough sea squirt/solitary tunicate | Solitary tunicate (Styela clava) enzymatic hydrolysates | Alcalase, Thermoase PC10F, pepsin, | AGS, DLD-1, HeLa | 577.1–1,240.0 µg/mL | Not mentioned | Kim, 2011 |
Japanese threadfin bream | Nemipterus japonicus tryptic hydrolysates | 4 h hydrolysis with trypsin at 37 °C | HepG2 liver cancer cells | 61.1 µg/mL | Inhibition of cell viability | Naqash and Nazeer, 2012 |
Beef sarcoplasmic protein hydrolysates | Gly-Phe-His-Ile, Asp-Phe-His-Ile-Asn-Gly, Phe-His-Asp, and Gly-Leu-Ser-Asp-Gly-Glu-Trp-Gln | Extraction with phosphate buffer followed by hydrolysis with thermolysin and proteinase A, trypsin, proteinase K, tyrosinase, pepsin, papain, protease (sequentially) | MCF-7, AGS, A549 | Not mentioned | Inhibition of cell viability | Jang et al., 2008 |
Bovine lactoferrin | LfcinB FKCRRWQWRMK KLGAPSITCVRRAF | Synthetic | Human umbilical vein endothelial cells | Not stated | Inhibition of angiogenesis | Mader et al, 2006 |
Milk | Casein phosphopeptide | Chemically synthesized | HT-29 intestinal tumour cells | Not mentioned | Apoptosis | Perego et al, 2011 |
Bovine milk | Whey protein isolate and collagen hydrolysate | Membrane ultrafiltration and RP-HPLC fractionation | B1F610 | 0.19–156.9 mg/mL | Apoptosis (increased caspase-3 expression) and necrosis | Castro et al, 2009 |
Bovine milk | PGPIPN immunomodulatory peptide | SKOV-3 | Not stated | Bcl-2 downregulation, apoptosis and inhibition of cell proliferation | Wang et al., 2013 |